审稿专家：曹依群

复旦大学附属肿瘤医院神经外科主任医师

参考文献

1.Iulia M. Lazar. (2025) Proteomic technologies for profiling cell-membrane/secretome interactions in brain metastatic cancer progression. Expert Review of Proteomics 22:8, pages 297-306.

2.Ardizzone A, Basilotta R, Filippone A, et al. Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. Cells. 2023 Mar;12(6):841. DOI: 10.3390/cells12060841. PMID: 36980182; PMCID: PMC10046911.

3.中国肿瘤整合诊治指南（CACA） 神经内分泌肿瘤（2025).中国抗癌协会神经内分泌肿瘤专业委员会.

4.Lleva RR, Inzucchi SE. Diagnosis and management of pituitary adenomas. Curr Opin Oncol. 2011 Jan;23(1):53-60. doi: 10.1097/CCO.0b013e328341000f. PMID: 21076304.

5.EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 2020 Jan 11;22(1):31-45. doi: 10.1093/neuonc/noz153. PMID: 31504802; PMCID: PMC6954440.

6.中国抗癌协会脑胶质瘤专业委员会,江涛,马文斌,等.中国抗癌协会脑胶质瘤整合诊疗指南(2024更新版)[J].中国微侵袭神经外科杂志, 2025, 29(11):631-642.DOI:10.11850/j.issn.1009-122X.2025.11.001.

7.86个罕见病病种诊疗指南.中华人民共和国卫生健康委员会, 2025

8.https://www.nccn.org/guidelines/guidelines-detail?category=1&id=142